Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Mark Y. Chan
, Mauricio G. Cohen
, Christopher K. Dyke
, Shelley K. Myles
, Laura G. Aberle
, Min Lin
, James Walder
, Steven R. Steinhubl
, Ian C. Gilchrist
, Neal S. Kleiman
, David A. Vorchheimer
, Nicholas Chronos
, Chiara Melloni
, John H. Alexander
, Robert A. Harrington
, Ross M. Tonkens
, Richard C. Becker
, Christopher P. Rusconi
Research output: Contribution to journal › Article › peer-review
132Scopus
citations
Fingerprint
Dive into the research topics of 'Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease'. Together they form a unique fingerprint.
Medicine and Dentistry
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science